25 XP   0   0   10

Trinity Biotech plc
Buy, Hold or Sell?

Let's analyse Trinity Biotech plc together

PenkeI guess you are interested in Trinity Biotech plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Trinity Biotech plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Trinity Biotech plc

I send you an email if I find something interesting about Trinity Biotech plc.

Quick analysis of Trinity Biotech plc (30 sec.)










What can you expect buying and holding a share of Trinity Biotech plc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$-3.13
Expected worth in 1 year
$-5.40
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-2.27
Return On Investment
-123.9%

For what price can you sell your share?

Current Price per Share
$1.83
Expected price per share
$1.79 - $2.08
How sure are you?
50%

1. Valuation of Trinity Biotech plc (5 min.)




Live pricePrice per Share (EOD)

$1.83

Intrinsic Value Per Share

$-29.56 - $-3.48

Total Value Per Share

$-32.69 - $-6.61

2. Growth of Trinity Biotech plc (5 min.)




Is Trinity Biotech plc growing?

Current yearPrevious yearGrowGrow %
How rich?-$23.9m$1.6m-$15.4m-112.2%

How much money is Trinity Biotech plc making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$8.6m$1.6m22.9%
Net Profit Margin-46.4%-49.6%--

How much money comes from the company's main activities?

3. Financial Health of Trinity Biotech plc (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#139 / 145

Most Revenue
#93 / 145

Most Profit
#99 / 145

What can you expect buying and holding a share of Trinity Biotech plc? (5 min.)

Welcome investor! Trinity Biotech plc's management wants to use your money to grow the business. In return you get a share of Trinity Biotech plc.

What can you expect buying and holding a share of Trinity Biotech plc?

First you should know what it really means to hold a share of Trinity Biotech plc. And how you can make/lose money.

Speculation

The Price per Share of Trinity Biotech plc is $1.83. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Trinity Biotech plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Trinity Biotech plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-3.13. Based on the TTM, the Book Value Change Per Share is $-0.57 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Trinity Biotech plc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.72-39.3%-0.63-34.6%-0.70-38.2%-0.33-18.2%-0.27-15.0%
Usd Book Value Change Per Share-0.85-46.6%-0.57-31.0%-0.21-11.7%-0.24-13.3%-0.27-14.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.8%
Usd Total Gains Per Share-0.85-46.6%-0.57-31.0%-0.21-11.7%-0.24-13.3%-0.25-13.8%
Usd Price Per Share0.43-0.76-1.09-1.68-6.48-
Price to Earnings Ratio-0.15--0.55--0.47-9.99-19.64-
Price-to-Total Gains Ratio-0.50--0.23--0.33--11.85--294.45-
Price to Book Ratio-0.14--4.39--22.57--21.95--10.02-
Price-to-Total Gains Ratio-0.50--0.23--0.33--11.85--294.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.83
Number of shares546
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.57-0.24
Usd Total Gains Per Share-0.57-0.24
Gains per Quarter (546 shares)-309.58-132.78
Gains per Year (546 shares)-1,238.33-531.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1238-12480-531-541
20-2477-24860-1062-1072
30-3715-37240-1593-1603
40-4953-49620-2125-2134
50-6192-62000-2656-2665
60-7430-74380-3187-3196
70-8668-86760-3718-3727
80-9907-99140-4249-4258
90-11145-111520-4780-4789
100-12383-123900-5311-5320

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%4.016.00.020.0%20.020.00.050.0%76.024.00.076.0%
Book Value Change Per Share1.03.00.025.0%4.06.02.033.3%5.011.04.025.0%14.018.08.035.0%50.033.017.050.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%6.00.034.015.0%16.00.084.016.0%
Total Gains per Share1.03.00.025.0%4.06.02.033.3%5.011.04.025.0%15.017.08.037.5%53.032.015.053.0%

Fundamentals of Trinity Biotech plc

About Trinity Biotech plc

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Fundamental data was last updated by Penke on 2024-04-12 20:20:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Trinity Biotech plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Trinity Biotech plc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -41.0% means that $-0.41 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Trinity Biotech plc:

  • The MRQ is -41.0%. The company is making a huge loss. -2
  • The TTM is -46.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-41.0%TTM-46.4%+5.5%
TTM-46.4%YOY-49.6%+3.2%
TTM-46.4%5Y-38.0%-8.4%
5Y-38.0%10Y-46.9%+8.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.0%-6.7%-34.3%
TTM-46.4%-6.7%-39.7%
YOY-49.6%0.3%-49.9%
5Y-38.0%-1.5%-36.5%
10Y-46.9%-3.4%-43.5%
1.1.2. Return on Assets

Shows how efficient Trinity Biotech plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • -9.3% Return on Assets means that Trinity Biotech plc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Trinity Biotech plc:

  • The MRQ is -9.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.3%TTM-9.8%+0.5%
TTM-9.8%YOY-8.8%-1.0%
TTM-9.8%5Y-6.9%-2.9%
5Y-6.9%10Y-6.6%-0.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.3%-1.3%-8.0%
TTM-9.8%-1.3%-8.5%
YOY-8.8%-0.9%-7.9%
5Y-6.9%-0.5%-6.4%
10Y-6.6%-0.9%-5.7%
1.1.3. Return on Equity

Shows how efficient Trinity Biotech plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Trinity Biotech plc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Trinity Biotech plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-31.7%+31.7%
TTM-5Y-45.9%+45.9%
5Y-45.9%10Y-31.6%-14.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.5%+0.5%
TTM--0.0%
YOY-31.7%0.3%-32.0%
5Y-45.9%-1.4%-44.5%
10Y-31.6%-2.3%-29.3%

1.2. Operating Efficiency of Trinity Biotech plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Trinity Biotech plc is operating .

  • Measures how much profit Trinity Biotech plc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • An Operating Margin of -26.0% means the company generated $-0.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Trinity Biotech plc:

  • The MRQ is -26.0%. The company is operating very inefficient. -2
  • The TTM is -27.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-26.0%TTM-27.3%+1.3%
TTM-27.3%YOY-16.9%-10.4%
TTM-27.3%5Y-1.8%-25.5%
5Y-1.8%10Y4.6%-6.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.0%-6.2%-19.8%
TTM-27.3%0.5%-27.8%
YOY-16.9%4.0%-20.9%
5Y-1.8%3.7%-5.5%
10Y4.6%-1.3%+5.9%
1.2.2. Operating Ratio

Measures how efficient Trinity Biotech plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.26 means that the operating costs are $1.26 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Trinity Biotech plc:

  • The MRQ is 1.260. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.280. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.260TTM1.280-0.021
TTM1.280YOY1.131+0.149
TTM1.2805Y1.000+0.280
5Y1.00010Y0.950+0.050
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2601.280-0.020
TTM1.2801.304-0.024
YOY1.1311.236-0.105
5Y1.0001.242-0.242
10Y0.9501.205-0.255

1.3. Liquidity of Trinity Biotech plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Trinity Biotech plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.60 means the company has $2.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Trinity Biotech plc:

  • The MRQ is 2.597. The company is able to pay all its short-term debts. +1
  • The TTM is 3.079. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.597TTM3.079-0.482
TTM3.079YOY2.786+0.292
TTM3.0795Y2.832+0.246
5Y2.83210Y4.254-1.422
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5972.111+0.486
TTM3.0792.298+0.781
YOY2.7862.599+0.187
5Y2.8323.012-0.180
10Y4.2543.081+1.173
1.3.2. Quick Ratio

Measures if Trinity Biotech plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.27 means the company can pay off $1.27 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Trinity Biotech plc:

  • The MRQ is 1.271. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 2.710. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.271TTM2.710-1.439
TTM2.710YOY1.517+1.193
TTM2.7105Y1.841+0.869
5Y1.84110Y2.964-1.123
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2711.204+0.067
TTM2.7101.319+1.391
YOY1.5171.602-0.085
5Y1.8411.943-0.102
10Y2.9642.203+0.761

1.4. Solvency of Trinity Biotech plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Trinity Biotech plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Trinity Biotech plc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 1.40 means that Trinity Biotech plc assets are financed with 140.3% credit (debt) and the remaining percentage (100% - 140.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Trinity Biotech plc:

  • The MRQ is 1.403. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.215. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.403TTM1.215+0.188
TTM1.215YOY0.988+0.227
TTM1.2155Y0.999+0.216
5Y0.99910Y0.724+0.275
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4030.429+0.974
TTM1.2150.407+0.808
YOY0.9880.394+0.594
5Y0.9990.450+0.549
10Y0.7240.450+0.274
1.4.2. Debt to Equity Ratio

Measures if Trinity Biotech plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Trinity Biotech plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.443-1.443
TTM-5Y11.875-11.875
5Y11.87510Y6.449+5.426
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.606-0.606
TTM-0.571-0.571
YOY1.4430.631+0.812
5Y11.8750.658+11.217
10Y6.4490.735+5.714

2. Market Valuation of Trinity Biotech plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Trinity Biotech plc generates.

  • Above 15 is considered overpriced but always compare Trinity Biotech plc to the Diagnostics & Research industry mean.
  • A PE ratio of -0.15 means the investor is paying $-0.15 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Trinity Biotech plc:

  • The EOD is -0.635. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.149. Based on the earnings, the company is expensive. -2
  • The TTM is -0.551. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.635MRQ-0.149-0.486
MRQ-0.149TTM-0.551+0.402
TTM-0.551YOY-0.474-0.077
TTM-0.5515Y9.992-10.543
5Y9.99210Y19.639-9.647
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.635-0.235-0.400
MRQ-0.149-0.395+0.246
TTM-0.551-0.284-0.267
YOY-0.4740.002-0.476
5Y9.9924.834+5.158
10Y19.6395.200+14.439
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Trinity Biotech plc:

  • The EOD is -1.883. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.441. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.701. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.883MRQ-0.441-1.441
MRQ-0.441TTM1.701-2.142
TTM1.701YOY-22.814+24.514
TTM1.7015Y-2.512+4.213
5Y-2.51210Y-46.322+43.810
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.883-0.277-1.606
MRQ-0.441-0.4410.000
TTM1.701-1.389+3.090
YOY-22.814-2.030-20.784
5Y-2.512-1.446-1.066
10Y-46.322-1.971-44.351
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Trinity Biotech plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -0.14 means the investor is paying $-0.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Trinity Biotech plc:

  • The EOD is -0.584. Based on the equity, the company is expensive. -2
  • The MRQ is -0.137. Based on the equity, the company is expensive. -2
  • The TTM is -4.390. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.584MRQ-0.137-0.447
MRQ-0.137TTM-4.390+4.253
TTM-4.390YOY-22.573+18.182
TTM-4.3905Y-21.954+17.564
5Y-21.95410Y-10.019-11.935
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.5841.897-2.481
MRQ-0.1372.222-2.359
TTM-4.3902.168-6.558
YOY-22.5733.041-25.614
5Y-21.9543.477-25.431
10Y-10.0194.125-14.144
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Trinity Biotech plc.

3.1. Institutions holding Trinity Biotech plc

Institutions are holding 39.293% of the shares of Trinity Biotech plc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Hunter Associates Inc.0.85110.12811625900-106495-6.1473
2023-12-31Stonehill Capital Management LLC0.7921.2752151297500
2023-12-31Renaissance Technologies Corp0.70870.00091353898-9300-0.6822
2023-12-31Acadian Asset Management LLC0.35850.0011684882-38654-5.3424
2023-12-31Whitefort Capital Management, LP.0.21440.11240951700
2023-12-31CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.05830.000211140000
2023-12-31Becker Capital0.04710.001490000900000
2023-12-31WEALTHSOURCE PARTNERS, LLC0.01580.00083020000
2023-12-31Aristides Capital LLC0.01470.004428057-134260-82.7147
2023-12-31State of New Jersey Common Pension Fd D0.014202706200
2023-12-31CI Private Wealth LLC0.0115022035220350
2023-12-31TWO SIGMA SECURITIES, LLC0.010.000119037190370
2023-12-31Millennium Management LLC0.0081015466154660
2023-12-31Morgan Stanley - Brokerage Accounts0.007601455200
2023-12-31Redwood Wealth Management Group LLC0.00740.006714150-2800-16.5192
2023-12-31Williams & Novak LLC0.00520.004910000100000
2023-12-31Dynamic Advisor Solutions LLC0.00520.00021000000
2023-12-31Rhumbline Advisers0.0010186000
2023-12-31CGC Financial services LLC0.00080.0003150000
2023-12-31Bank of America Corp0.00060120400
Total 3.13221.53635983695-134971-2.3%

3.2. Funds holding Trinity Biotech plc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.01350103300
Total 0.01350103300.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Trinity Biotech plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.853-0.567-34%-0.213-75%-0.243-71%-0.267-69%
Book Value Per Share---3.134-1.740-44%-0.130-96%-0.112-96%2.761-214%
Current Ratio--2.5973.079-16%2.786-7%2.832-8%4.254-39%
Debt To Asset Ratio--1.4031.215+15%0.988+42%0.999+40%0.724+94%
Debt To Equity Ratio----0%1.443-100%11.875-100%6.449-100%
Dividend Per Share----0%-0%-0%0.014-100%
Eps---0.720-0.633-12%-0.698-3%-0.333-54%-0.274-62%
Free Cash Flow Per Share---0.243-0.388+60%-0.060-75%-0.089-63%-0.073-70%
Free Cash Flow To Equity Per Share---0.316-0.937+197%-0.118-63%-0.276-13%-0.128-59%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.690+45%
Intrinsic Value_10Y_max---3.480--------
Intrinsic Value_10Y_min---29.557--------
Intrinsic Value_1Y_max---0.300--------
Intrinsic Value_1Y_min---0.943--------
Intrinsic Value_3Y_max---0.938--------
Intrinsic Value_3Y_min---4.599--------
Intrinsic Value_5Y_max---1.621--------
Intrinsic Value_5Y_min---10.162--------
Market Cap13983963.300+77%3278207.79013004126.390-75%18424820.169-82%39159000.512-92%166739808.469-98%
Net Profit Margin---0.410-0.464+13%-0.496+21%-0.380-7%-0.469+15%
Operating Margin---0.260-0.273+5%-0.169-35%-0.018-93%0.046-671%
Operating Ratio--1.2601.280-2%1.131+11%1.000+26%0.950+33%
Pb Ratio-0.584-327%-0.137-4.390+3107%-22.573+16390%-21.954+15939%-10.019+7219%
Pe Ratio-0.635-327%-0.149-0.551+270%-0.474+218%9.992-101%19.639-101%
Price Per Share1.830+77%0.4290.764-44%1.087-61%1.677-74%6.484-93%
Price To Free Cash Flow Ratio-1.883-327%-0.4411.701-126%-22.814+5069%-2.512+469%-46.322+10396%
Price To Total Gains Ratio-2.146-327%-0.503-0.233-54%-0.330-34%-11.851+2256%-294.446+58433%
Quick Ratio--1.2712.710-53%1.517-16%1.841-31%2.964-57%
Return On Assets---0.093-0.098+6%-0.088-5%-0.069-25%-0.066-29%
Return On Equity----0%-0.3170%-0.4590%-0.3160%
Total Gains Per Share---0.853-0.567-34%-0.213-75%-0.243-71%-0.253-70%
Usd Book Value---23949000.000-13748000.000-43%1676500.000-1529%4255700.000-663%76551325.000-131%
Usd Book Value Change Per Share---0.853-0.567-34%-0.213-75%-0.243-71%-0.267-69%
Usd Book Value Per Share---3.134-1.740-44%-0.130-96%-0.112-96%2.761-214%
Usd Dividend Per Share----0%-0%-0%0.014-100%
Usd Eps---0.720-0.633-12%-0.698-3%-0.333-54%-0.274-62%
Usd Free Cash Flow---1857000.000-2746500.000+48%-240500.000-87%-509300.000-73%-987375.000-47%
Usd Free Cash Flow Per Share---0.243-0.388+60%-0.060-75%-0.089-63%-0.073-70%
Usd Free Cash Flow To Equity Per Share---0.316-0.937+197%-0.118-63%-0.276-13%-0.128-59%
Usd Market Cap13983963.300+77%3278207.79013004126.390-75%18424820.169-82%39159000.512-92%166739808.469-98%
Usd Price Per Share1.830+77%0.4290.764-44%1.087-61%1.677-74%6.484-93%
Usd Profit---5502000.000-7071750.000+29%-8692750.000+58%-7550950.000+37%-10394025.000+89%
Usd Revenue--13428000.00015009750.000-11%17713500.000-24%21304200.000-37%23242200.000-42%
Usd Total Gains Per Share---0.853-0.567-34%-0.213-75%-0.243-71%-0.253-70%
 EOD+6 -2MRQTTM+12 -19YOY+4 -285Y+5 -2710Y+7 -28

4.2. Fundamental Score

Let's check the fundamental score of Trinity Biotech plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.635
Price to Book Ratio (EOD)Between0-1-0.584
Net Profit Margin (MRQ)Greater than0-0.410
Operating Margin (MRQ)Greater than0-0.260
Quick Ratio (MRQ)Greater than11.271
Current Ratio (MRQ)Greater than12.597
Debt to Asset Ratio (MRQ)Less than11.403
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.093
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Trinity Biotech plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.778
Ma 20Greater thanMa 501.900
Ma 50Greater thanMa 1002.110
Ma 100Greater thanMa 2002.262
OpenGreater thanClose1.880
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -5,76475-5,68984-5,605-125-5,7306,7331,003



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets59,435
Total Liabilities83,384
Total Stockholder Equity-23,949
 As reported
Total Liabilities 83,384
Total Stockholder Equity+ -23,949
Total Assets = 59,435

Assets

Total Assets59,435
Total Current Assets39,041
Long-term Assets20,394
Total Current Assets
Cash And Cash Equivalents 3,691
Net Receivables 15,417
Inventory 19,933
Total Current Assets  (as reported)39,041
Total Current Assets  (calculated)39,041
+/-0
Long-term Assets
Property Plant Equipment 1,892
Long-term Assets Other 79
Long-term Assets  (as reported)20,394
Long-term Assets  (calculated)1,971
+/- 18,423

Liabilities & Shareholders' Equity

Total Current Liabilities15,035
Long-term Liabilities68,349
Total Stockholder Equity-23,949
Total Current Liabilities
Short-term Debt 210
Accounts payable 14,496
Other Current Liabilities 50
Total Current Liabilities  (as reported)15,035
Total Current Liabilities  (calculated)14,756
+/- 279
Long-term Liabilities
Long-term Liabilities  (as reported)68,349
Long-term Liabilities  (calculated)0
+/- 68,349
Total Stockholder Equity
Common Stock1,972
Retained Earnings -48,644
Accumulated Other Comprehensive Income 1,003
Other Stockholders Equity 21,720
Total Stockholder Equity (as reported)-23,949
Total Stockholder Equity (calculated)-23,949
+/-0
Other
Cash and Short Term Investments 3,691
Common Stock Shares Outstanding 1,533
Current Deferred Revenue279
Liabilities and Stockholders Equity 59,435
Net Debt 51,170
Net Working Capital 24,006
Short Long Term Debt Total 54,861



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-06-301994-03-311993-12-311993-09-301993-06-301993-03-31
> Total Assets 
0
0
0
4,900
0
0
0
0
0
9,200
0
0
0
13,400
0
0
0
24,600
0
27,000
24,600
45,000
43,600
47,100
45,800
45,000
45,042
57,923
59,797
67,231
67,627
67,231
70,986
77,029
78,354
77,029
80,654
89,268
91,892
89,268
112,422
118,091
118,091
153,260
153,616
150,828
150,828
160,776
178,427
184,602
178,602
240,952
245,644
249,131
249,131
248,368
246,147
215,979
215,979
216,777
215,657
129,509
129,509
131,213
130,343
132,445
132,445
153,256
157,982
160,874
160,874
168,029
169,511
171,499
171,499
183,953
189,907
197,407
197,407
203,443
222,880
226,486
226,486
238,449
236,996
242,840
246,775
359,764
355,377
358,959
358,959
357,770
360,468
249,592
249,592
244,798
244,624
192,615
192,615
194,449
183,327
151,235
151,235
171,704
173,252
131,071
131,071
128,728
136,075
130,397
130,397
124,724
122,779
118,895
118,895
107,141
92,104
91,157
92,104
71,990
63,597
59,435
59,43563,59771,99092,10491,15792,104107,141118,895118,895122,779124,724130,397130,397136,075128,728131,071131,071173,252171,704151,235151,235183,327194,449192,615192,615244,624244,798249,592249,592360,468357,770358,959358,959355,377359,764246,775242,840236,996238,449226,486226,486222,880203,443197,407197,407189,907183,953171,499171,499169,511168,029160,874160,874157,982153,256132,445132,445130,343131,213129,509129,509215,657216,777215,979215,979246,147248,368249,131249,131245,644240,952178,602184,602178,427160,776150,828150,828153,616153,260118,091118,091112,42289,26891,89289,26880,65477,02978,35477,02970,98667,23167,62767,23159,79757,92345,04245,00045,80047,10043,60045,00024,60027,000024,60000013,4000009,200000004,900000
   > Total Current Assets 
0
0
0
2,300
0
0
0
0
0
8,200
0
0
0
9,700
0
0
0
15,800
0
15,700
15,800
18,100
16,900
20,100
19,100
19,800
19,787
29,045
29,370
26,658
27,276
26,658
30,271
29,309
31,060
29,309
33,486
38,625
41,288
38,625
60,074
65,031
65,031
80,833
80,657
75,686
75,686
72,291
77,661
76,865
70,310
93,910
97,293
97,376
97,376
93,699
0
79,809
79,809
78,305
76,643
75,201
75,201
74,516
71,772
68,436
68,436
96,955
100,099
101,324
101,324
114,278
113,934
115,013
115,013
109,613
111,753
110,497
110,497
106,828
77,520
76,742
76,742
75,513
68,057
69,050
70,670
177,006
168,443
163,230
163,230
152,717
151,353
133,488
133,488
123,673
121,270
112,592
112,592
108,669
93,479
86,661
86,661
81,997
81,104
71,390
71,390
65,689
72,369
83,300
83,300
81,463
78,247
72,688
72,688
57,237
46,668
58,262
46,668
52,918
43,828
39,041
39,04143,82852,91846,66858,26246,66857,23772,68872,68878,24781,46383,30083,30072,36965,68971,39071,39081,10481,99786,66186,66193,479108,669112,592112,592121,270123,673133,488133,488151,353152,717163,230163,230168,443177,00670,67069,05068,05775,51376,74276,74277,520106,828110,497110,497111,753109,613115,013115,013113,934114,278101,324101,324100,09996,95568,43668,43671,77274,51675,20175,20176,64378,30579,80979,809093,69997,37697,37697,29393,91070,31076,86577,66172,29175,68675,68680,65780,83365,03165,03160,07438,62541,28838,62533,48629,30931,06029,30930,27126,65827,27626,65829,37029,04519,78719,80019,10020,10016,90018,10015,80015,700015,8000009,7000008,200000002,300000
       Cash And Cash Equivalents 
0
0
0
900
0
0
0
0
0
7,500
0
0
0
4,900
0
0
0
2,800
0
1,100
2,800
1,300
1,000
1,200
1,200
3,100
3,064
10,945
9,901
4,276
3,843
4,276
5,416
5,282
6,206
5,282
5,422
5,768
4,218
5,768
20,715
20,563
20,563
25,578
17,079
22,287
22,287
17,951
19,286
4,916
757
3,037
4,572
2,821
2,821
9,069
0
8,700
8,700
6,246
3,502
5,184
5,184
4,791
3,697
6,078
6,078
50,042
53,802
58,002
58,002
71,422
71,128
71,085
71,085
73,605
74,455
74,947
74,947
66,164
26,806
22,317
22,317
15,153
8,949
9,102
5,745
110,257
104,289
101,953
101,953
84,920
84,751
77,108
77,108
63,977
62,529
57,607
57,607
49,426
35,679
30,277
30,277
24,990
25,090
16,400
16,400
15,570
19,910
27,327
27,327
0
0
25,910
25,910
10,453
6,578
-13,587
6,578
-13,190
-12,521
3,691
3,691-12,521-13,1906,578-13,5876,57810,45325,91025,9100027,32727,32719,91015,57016,40016,40025,09024,99030,27730,27735,67949,42657,60757,60762,52963,97777,10877,10884,75184,920101,953101,953104,289110,2575,7459,1028,94915,15322,31722,31726,80666,16474,94774,94774,45573,60571,08571,08571,12871,42258,00258,00253,80250,0426,0786,0783,6974,7915,1845,1843,5026,2468,7008,70009,0692,8212,8214,5723,0377574,91619,28617,95122,28722,28717,07925,57820,56320,56320,7155,7684,2185,7685,4225,2826,2065,2825,4164,2763,8434,2769,90110,9453,0643,1001,2001,2001,0001,3002,8001,10002,8000004,9000007,50000000900000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,965
33
0
67
15,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,043
0
0
0
0
0
0
0
1,169
1,169
0
0
0
0
0
0
0
0
0
0
17,119
17,119
27,418
18,782
0
018,78227,41817,11917,11900000000001,1691,169000000034,043000000000000000000000000000000000000000000015,500670334,965000000000000000000000000100100100100000000000000000000000
       Net Receivables 
0
0
0
400
0
0
0
0
0
400
0
0
0
3,500
0
0
0
7,900
0
7,600
7,900
6,700
6,100
8,400
8,000
7,200
7,212
7,860
8,790
7,970
8,237
7,970
8,890
5,725
8,397
5,725
10,703
12,494
14,091
12,494
14,594
12,067
12,067
18,693
25,317
11,781
11,781
17,758
19,608
19,488
22,250
36,107
35,562
29,991
29,991
32,411
0
24,800
24,800
29,398
30,493
27,700
27,700
27,714
26,537
23,160
23,160
28,849
27,539
25,746
25,746
23,885
23,328
11,533
11,533
15,214
15,871
14,793
14,793
17,741
23,327
24,755
24,755
27,251
25,329
26,431
27,861
28,556
27,272
26,152
26,152
28,544
26,613
23,791
23,791
26,076
26,030
22,180
22,180
24,425
24,912
26,025
26,025
25,520
26,054
22,969
22,969
18,646
22,852
24,595
24,595
18,140
18,656
15,710
15,710
17,675
17,587
15,452
17,587
16,106
16,687
15,417
15,41716,68716,10617,58715,45217,58717,67515,71015,71018,65618,14024,59524,59522,85218,64622,96922,96926,05425,52026,02526,02524,91224,42522,18022,18026,03026,07623,79123,79126,61328,54426,15226,15227,27228,55627,86126,43125,32927,25124,75524,75523,32717,74114,79314,79315,87115,21411,53311,53323,32823,88525,74625,74627,53928,84923,16023,16026,53727,71427,70027,70030,49329,39824,80024,800032,41129,99129,99135,56236,10722,25019,48819,60817,75811,78111,78125,31718,69312,06712,06714,59412,49414,09112,49410,7035,7258,3975,7258,8907,9708,2377,9708,7907,8607,2127,2008,0008,4006,1006,7007,9007,60007,9000003,50000040000000400000
       Other Current Assets 
0
0
0
600
0
0
0
0
0
0
0
0
0
800
0
0
0
1,400
0
1,600
1,400
0
0
-100
0
0
7,715
7,860
8,790
1,746
100
100
8,890
447
8,397
447
10,703
-100
14,091
15,607
14,594
465
465
-100
-100
675
675
599
138
90
9,000
17,124
15,500
18,992
18,992
0
0
224
224
296
0
736
-100
344
284
-100
0
100
0
2,331
0
0
0
12,557
12,557
0
0
1,216
1,216
0
0
3,106
3,106
-100
100
4,852
27,861
-100
-100
5,496
5,496
28,544
26,613
3,634
3,634
26
100
2,998
2,998
23,138
23,380
807
807
0
0
576
576
0
19,910
1,159
1,159
0
0
1,945
1,945
1,762
1,932
17,746
17,746
2,240
0
0
002,24017,74617,7461,9321,7621,9451,945001,1591,15919,91005765760080780723,38023,1382,9982,998100263,6343,63426,61328,5445,4965,496-100-10027,8614,852100-1003,1063,106001,2161,2160012,55712,5570002,33101000-100284344-10073602962242240018,99218,99215,50017,1249,00090138599675675-100-10046546514,59415,60714,091-10010,7034478,3974478,8901001001,7468,7907,8607,71500-100001,4001,60001,400000800000000000600000
   > Long-term Assets 
0
0
0
2,600
0
0
0
0
0
1,000
0
0
0
3,700
0
0
0
8,800
0
11,300
8,800
26,900
26,700
27,000
26,700
25,200
25,255
28,878
30,427
40,573
40,351
40,573
40,715
47,720
47,294
47,720
47,168
50,642
50,604
50,642
52,348
53,061
53,061
72,427
72,959
75,142
75,142
88,485
100,766
107,737
108,292
147,042
148,351
151,755
151,755
154,669
0
136,170
136,170
138,472
139,014
54,308
54,308
56,697
58,571
64,009
64,009
56,301
57,883
59,550
59,550
53,751
55,577
56,486
56,486
74,340
78,154
86,910
86,910
96,615
145,360
149,744
149,744
162,936
168,939
173,790
176,105
182,758
186,934
195,729
195,729
205,053
209,115
116,104
116,104
121,125
123,354
80,023
80,023
85,780
89,848
64,574
64,574
89,707
92,148
59,681
59,681
63,039
63,706
47,097
47,097
43,261
44,532
46,207
46,207
49,904
45,436
32,895
45,436
19,072
19,769
20,394
20,39419,76919,07245,43632,89545,43649,90446,20746,20744,53243,26147,09747,09763,70663,03959,68159,68192,14889,70764,57464,57489,84885,78080,02380,023123,354121,125116,104116,104209,115205,053195,729195,729186,934182,758176,105173,790168,939162,936149,744149,744145,36096,61586,91086,91078,15474,34056,48656,48655,57753,75159,55059,55057,88356,30164,00964,00958,57156,69754,30854,308139,014138,472136,170136,1700154,669151,755151,755148,351147,042108,292107,737100,76688,48575,14275,14272,95972,42753,06153,06152,34850,64250,60450,64247,16847,72047,29447,72040,71540,57340,35140,57330,42728,87825,25525,20026,70027,00026,70026,9008,80011,30008,8000003,7000001,000000002,600000
       Property Plant Equipment 
0
0
0
1,000
0
0
0
0
0
900
0
0
0
1,300
0
0
0
5,800
0
7,300
5,800
8,400
8,400
8,800
9,100
4,700
4,696
4,639
5,264
5,469
5,500
5,469
5,834
5,967
5,995
5,967
7,110
9,879
10,100
9,879
11,071
13,660
13,660
14,642
14,760
15,942
15,942
16,778
19,339
19,202
19,003
21,694
21,824
22,255
22,255
22,622
24,767
26,409
26,409
25,574
25,266
11,855
11,855
11,908
12,143
12,174
12,174
5,339
5,535
5,999
5,999
7,260
7,603
7,626
7,626
8,242
8,618
8,883
8,883
10,189
12,090
12,991
12,991
14,784
15,782
17,877
17,760
19,212
19,198
20,659
20,659
21,760
21,495
13,403
13,403
14,462
15,191
5,800
5,800
7,769
10,046
5,362
5,362
26,293
26,306
9,290
9,290
9,297
9,462
8,547
8,547
6,501
6,258
5,918
5,918
6,261
5,682
5,496
5,682
1,869
1,804
1,892
1,8921,8041,8695,6825,4965,6826,2615,9185,9186,2586,5018,5478,5479,4629,2979,2909,29026,30626,2935,3625,36210,0467,7695,8005,80015,19114,46213,40313,40321,49521,76020,65920,65919,19819,21217,76017,87715,78214,78412,99112,99112,09010,1898,8838,8838,6188,2427,6267,6267,6037,2605,9995,9995,5355,33912,17412,17412,14311,90811,85511,85525,26625,57426,40926,40924,76722,62222,25522,25521,82421,69419,00319,20219,33916,77815,94215,94214,76014,64213,66013,66011,0719,87910,1009,8797,1105,9675,9955,9675,8345,4695,5005,4695,2644,6394,6964,7009,1008,8008,4008,4005,8007,30005,8000001,300000900000001,000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,896
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54,938
85,914
118,956
119,753
76,617
76,617
123,798
0
44,485
44,485
107,671
108,829
20,053
20,053
0
0
20,053
20,053
0
0
17,828
17,828
0
0
19,629
19,629
0
0
26,747
26,747
0
0
53,251
53,251
0
0
53,106
0
0
0
52,686
52,686
0
0
25,774
25,774
0
0
17,898
17,898
0
0
16,141
16,141
0
0
12,591
12,591
0
0
12,591
12,591
0
0
12,537
12,537
0
12,537
12,537
12,537
0
0
0
00012,53712,53712,537012,53712,5370012,59112,5910012,59112,5910016,14116,1410017,89817,8980025,77425,7740052,68652,68600053,1060053,25153,2510026,74726,7470019,62919,6290017,82817,8280020,05320,0530020,05320,053108,829107,67144,48544,4850123,79876,61776,617119,753118,95685,91454,938000000000000000000030,89600000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,690
0
0
0
4,690
0
0
0
0
0
0
0
360
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
0
0
0
0001,5000000000000000000000036000000004,6900004,6900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,700
0
0
0
0
0
0
0
0
0
0
0
0
0
400
0
1,500
400
17,900
17,700
17,600
17,000
20,600
20,559
24,239
25,163
33,762
33,539
33,762
33,289
40,402
40,029
40,402
38,996
39,605
39,435
39,605
40,309
38,851
38,851
57,785
58,199
57,870
57,870
68,805
77,681
85,197
85,900
119,000
119,800
45,151
45,151
123,798
127,364
60,443
60,443
107,671
108,800
18,472
18,472
46,200
42,900
24,769
24,769
35,100
36,100
19,420
19,420
41,800
43,500
25,761
25,761
62,300
65,600
46,299
46,299
80,500
126,324
75,296
75,296
137,848
141,800
91,918
147,568
152,338
156,326
108,672
108,672
169,049
173,240
61,501
61,501
90,438
92,185
46,856
46,856
68,263
69,804
36,810
36,810
56,079
57,948
31,063
31,063
46,751
-40,805
21,269
21,269
0
0
23,444
23,444
38,743
22,732
21,330
22,732
15,756
0
0
0015,75622,73221,33022,73238,74323,44423,4440021,26921,269-40,80546,75131,06331,06357,94856,07936,81036,81069,80468,26346,85646,85692,18590,43861,50161,501173,240169,049108,672108,672156,326152,338147,56891,918141,800137,84875,29675,296126,32480,50046,29946,29965,60062,30025,76125,76143,50041,80019,42019,42036,10035,10024,76924,76942,90046,20018,47218,472108,800107,67160,44360,443127,364123,79845,15145,151119,800119,00085,90085,19777,68168,80557,87057,87058,19957,78538,85138,85140,30939,60539,43539,60538,99640,40240,02940,40233,28933,76233,53933,76225,16324,23920,55920,60017,00017,60017,70017,9004001,500040000000000000001,700000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,487
24,239
25,163
35,103
34,951
34,572
34,881
41,753
41,299
40,442
40,058
40,764
40,504
40,331
41,277
39,400
39,796
57,785
59,418
59,200
71,043
71,707
81,427
88,535
89,289
125,348
126,527
129,500
130,389
132,047
135,008
109,761
110,960
112,898
113,748
42,453
43,402
44,789
46,428
51,835
53,204
50,962
52,348
53,551
56,381
46,491
47,974
48,860
63,394
66,098
69,536
78,027
82,226
86,426
133,270
136,753
142,582
148,152
153,157
156,016
158,345
163,546
167,736
179,794
179,113
183,293
187,620
102,701
104,493
106,663
108,163
74,583
9,747
9,748
9,998
32,950
6,531
7,335
7,894
29,515
6,950
6,991
6,368
18,134
4,520
3,896
3,955
4,308
4,872
4,900
4,835
0
4,569
1,447
0
0
001,4474,56904,8354,9004,8724,3083,9553,8964,52018,1346,3686,9916,95029,5157,8947,3356,53132,9509,9989,7489,74774,583108,163106,663104,493102,701187,620183,293179,113179,794167,736163,546158,345156,016153,157148,152142,582136,753133,27086,42682,22678,02769,53666,09863,39448,86047,97446,49156,38153,55152,34850,96253,20451,83546,42844,78943,40242,453113,748112,898110,960109,761135,008132,047130,389129,500126,527125,34889,28988,53581,42771,70771,04359,20059,41857,78539,79639,40041,27740,33140,50440,76440,05840,44241,29941,75334,88134,57234,95135,10325,16324,23924,48700000000000000000000000000
> Total Liabilities 
0
0
0
1,800
0
0
0
0
0
1,700
0
0
0
2,800
0
0
0
17,500
0
18,200
17,500
30,400
28,000
29,900
27,500
22,100
22,320
14,218
10,968
12,188
11,515
12,188
12,720
20,498
20,528
20,498
20,478
26,359
26,279
26,359
39,433
37,830
37,830
38,121
37,022
34,690
34,690
33,792
46,528
50,984
43,136
82,588
82,570
81,869
81,869
72,543
69,537
79,134
79,134
69,474
67,843
63,604
63,604
59,094
54,165
53,101
53,101
20,567
21,239
19,587
19,587
20,941
20,540
20,167
20,167
24,275
24,850
28,027
28,027
28,626
47,750
43,475
43,475
42,341
42,217
45,865
45,536
154,703
144,380
145,071
145,071
147,107
150,068
140,865
140,865
137,932
138,237
127,419
127,419
127,755
115,244
107,181
107,181
132,632
134,320
126,358
126,358
129,440
129,004
132,616
132,616
125,220
121,969
119,214
119,214
91,322
94,280
97,775
94,280
83,370
81,084
83,384
83,38481,08483,37094,28097,77594,28091,322119,214119,214121,969125,220132,616132,616129,004129,440126,358126,358134,320132,632107,181107,181115,244127,755127,419127,419138,237137,932140,865140,865150,068147,107145,071145,071144,380154,70345,53645,86542,21742,34143,47543,47547,75028,62628,02728,02724,85024,27520,16720,16720,54020,94119,58719,58721,23920,56753,10153,10154,16559,09463,60463,60467,84369,47479,13479,13469,53772,54381,86981,86982,57082,58843,13650,98446,52833,79234,69034,69037,02238,12137,83037,83039,43326,35926,27926,35920,47820,49820,52820,49812,72012,18811,51512,18810,96814,21822,32022,10027,50029,90028,00030,40017,50018,200017,5000002,8000001,700000001,800000
   > Total Current Liabilities 
0
0
0
1,700
0
0
0
0
0
1,700
0
0
0
3,000
0
0
0
8,800
0
8,800
8,800
18,100
16,200
19,600
18,500
14,200
14,234
7,807
5,271
9,922
9,345
9,922
7,839
12,692
12,959
12,692
13,735
18,614
19,242
18,614
14,538
19,401
19,401
14,334
15,109
20,260
20,260
21,256
28,255
31,901
27,173
34,461
38,398
35,941
35,941
33,495
33,673
43,511
43,511
32,729
34,550
35,707
35,707
33,307
31,185
25,601
25,601
13,091
13,600
12,256
12,256
13,149
12,425
13,329
13,329
13,550
13,906
13,966
13,966
14,628
22,984
20,976
20,976
17,217
15,781
22,056
20,658
20,328
19,720
20,112
20,112
20,116
20,823
25,278
25,278
23,229
23,500
21,230
21,230
20,796
20,867
17,604
17,604
24,407
25,902
19,449
19,449
22,750
23,096
27,058
27,058
105,621
102,877
100,491
100,491
13,881
17,339
16,150
17,339
14,760
12,738
15,035
15,03512,73814,76017,33916,15017,33913,881100,491100,491102,877105,62127,05827,05823,09622,75019,44919,44925,90224,40717,60417,60420,86720,79621,23021,23023,50023,22925,27825,27820,82320,11620,11220,11219,72020,32820,65822,05615,78117,21720,97620,97622,98414,62813,96613,96613,90613,55013,32913,32912,42513,14912,25612,25613,60013,09125,60125,60131,18533,30735,70735,70734,55032,72943,51143,51133,67333,49535,94135,94138,39834,46127,17331,90128,25521,25620,26020,26015,10914,33419,40119,40114,53818,61419,24218,61413,73512,69212,95912,6927,8399,9229,3459,9225,2717,80714,23414,20018,50019,60016,20018,1008,8008,80008,8000003,0000001,700000001,700000
       Short-term Debt 
0
0
0
100
0
0
0
0
0
100
0
0
0
0
0
0
0
200
0
0
200
5,000
0
0
0
4,582
4,582
0
0
1,489
0
1,489
0
3,816
0
3,816
0
0
0
0
0
5,603
5,603
0
0
10,419
10,419
10,448
11,854
14,923
14,983
14,837
14,072
15,338
15,338
10,434
0
15,821
15,821
10,736
12,862
12,656
12,656
13,943
14,164
12,625
12,625
246
265
162
162
176
152
108
108
30
0
-7,299
-7,299
0
0
-11,977
-11,977
0
0
-11,727
0
0
0
271
271
0
101,351
273
273
95,245
95,316
354
354
95,179
0
436
436
0
0
2,404
2,404
0
0
5,058
5,058
83,190
83,159
85,292
85,292
2,028
210
1,771
210
1,853
1,810
210
2101,8101,8532101,7712102,02885,29285,29283,15983,1905,0585,058002,4042,40400436436095,17935435495,31695,245273273101,3510271271000-11,72700-11,977-11,97700-7,299-7,29903010810815217616216226524612,62512,62514,16413,94312,65612,65612,86210,73615,82115,821010,43415,33815,33814,07214,83714,98314,92311,85410,44810,41910,419005,6035,603000003,81603,81601,48901,489004,5824,5820005,00020000200000000010000000100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
271
0
0
0
92,827
0
0
101,351
93,237
95,462
95,245
95,316
93,841
95,167
95,179
0
0
0
0
0
0
0
0
0
2,905
0
83,190
83,159
83,312
210
210
210
210
210
210
210
0
021021021021021021021083,31283,15983,19002,90500000000095,17995,16793,84195,31695,24595,46293,237101,3510092,8270002710000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1,000
0
0
0
0
0
300
0
0
0
1,500
0
0
0
3,800
0
0
3,800
2,600
16,200
19,600
18,500
11,000
2,367
7,800
5,300
4,286
9,345
4,286
7,839
1,714
12,959
1,714
13,735
18,350
19,242
18,350
14,538
3,518
3,518
14,334
15,109
3,328
3,328
10,128
15,805
6,065
11,267
14,729
19,336
7,752
7,752
19,735
19,885
8,454
8,454
21,651
21,212
22,969
22,969
19,279
16,907
12,844
12,844
12,241
12,831
11,447
11,447
12,153
11,411
11,589
11,589
11,766
11,795
12,824
12,824
13,344
21,587
20,131
20,131
16,106
15,151
21,196
20,116
19,756
18,694
18,874
18,874
19,384
19,976
25,028
25,028
22,572
22,923
20,845
20,845
20,494
20,682
17,344
17,344
18,472
20,135
19,351
19,351
22,327
22,281
7,103
7,103
21,304
18,324
6,763
6,763
11,782
17,051
12,910
17,051
12,570
10,626
14,496
14,49610,62612,57017,05112,91017,05111,7826,7636,76318,32421,3047,1037,10322,28122,32719,35119,35120,13518,47217,34417,34420,68220,49420,84520,84522,92322,57225,02825,02819,97619,38418,87418,87418,69419,75620,11621,19615,15116,10620,13120,13121,58713,34412,82412,82411,79511,76611,58911,58911,41112,15311,44711,44712,83112,24112,84412,84416,90719,27922,96922,96921,21221,6518,4548,45419,88519,7357,7527,75219,33614,72911,2676,06515,80510,1283,3283,32815,10914,3343,5183,51814,53818,35019,24218,35013,7351,71412,9591,7147,8394,2869,3454,2865,3007,8002,36711,00018,50019,60016,2002,6003,800003,8000001,500000300000001,000000
       Other Current Liabilities 
0
0
0
600
0
0
0
0
0
1,300
0
0
0
1,500
0
0
0
4,800
0
0
4,800
10,500
0
0
0
-1,382
7,285
7
-29
4,147
0
4,147
0
1,397
0
1,397
0
264
0
264
0
3,587
3,587
0
1,200
1,279
1,279
680
596
4,593
923
4,895
4,990
9,980
9,980
3,326
2,785
17,782
17,782
342
476
27
27
85
114
58
58
406
88
647
647
820
862
1,632
1,632
1,754
2,111
8,191
8,191
1,284
1,397
12,678
12,678
1,111
630
12,387
542
572
1,026
780
780
732
847
-247
-247
657
577
-247
-247
302
185
-488
-488
5,935
5,767
-2,598
-2,598
423
815
10,452
10,452
1,127
1,394
8,295
8,295
71
-36
1,386
-36
337
302
50
50302337-361,386-36718,2958,2951,3941,12710,45210,452815423-2,598-2,5985,7675,935-488-488185302-247-247577657-247-2478477327807801,02657254212,3876301,11112,67812,6781,3971,2848,1918,1912,1111,7541,6321,63286282064764788406585811485272747634217,78217,7822,7853,3269,9809,9804,9904,8959234,5935966801,2791,2791,20003,5873,5870264026401,39701,39704,14704,147-2977,285-1,38200010,5004,800004,8000001,5000001,30000000600000
   > Long-term Liabilities 
0
0
0
100
0
0
0
0
0
400
0
0
0
-200
0
0
0
8,700
0
9,400
8,700
12,300
11,800
10,300
9,000
7,900
8,086
6,411
5,697
2,266
2,170
2,266
4,881
7,805
7,569
7,805
6,743
7,745
7,037
7,745
24,895
18,429
18,429
23,787
21,913
14,430
14,430
12,536
18,273
19,083
15,963
48,127
44,172
45,928
45,928
39,048
0
35,623
35,623
36,745
33,293
27,897
27,897
25,787
22,980
27,500
27,500
7,476
7,639
7,331
7,331
7,792
8,115
6,838
6,838
10,725
10,944
14,061
14,061
13,998
24,766
22,499
22,499
25,124
26,436
23,809
24,878
134,375
124,660
124,959
124,959
126,991
129,245
115,587
115,587
114,703
114,737
106,189
106,189
106,959
94,377
89,577
89,577
108,225
108,418
106,909
106,909
106,690
105,908
105,558
105,558
19,599
19,092
18,723
18,723
77,441
76,941
81,625
76,941
68,610
68,346
68,349
68,34968,34668,61076,94181,62576,94177,44118,72318,72319,09219,599105,558105,558105,908106,690106,909106,909108,418108,22589,57789,57794,377106,959106,189106,189114,737114,703115,587115,587129,245126,991124,959124,959124,660134,37524,87823,80926,43625,12422,49922,49924,76613,99814,06114,06110,94410,7256,8386,8388,1157,7927,3317,3317,6397,47627,50027,50022,98025,78727,89727,89733,29336,74535,62335,623039,04845,92845,92844,17248,12715,96319,08318,27312,53614,43014,43021,91323,78718,42918,42924,8957,7457,0377,7456,7437,8057,5697,8054,8812,2662,1702,2665,6976,4118,0867,9009,00010,30011,80012,3008,7009,40008,700000-20000040000000100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
82,051
81,620
81,942
81,793
81,865
99,766
82,185
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000082,18599,76681,86581,79381,94281,62082,0510000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,736
7,569
6,763
6,743
642
4,862
4,910
4,895
911
4,952
6,263
1,257
1,346
3,426
3,642
4,189
150
151
2,645
2,684
3,406
3,257
463
463
74
74
73
74
59
59
59
59
59
38
607
519
30
52
62
16
10
3,273
3,269
3,291
4,318
3,344
2,325
5,959
4,596
4,634
4,665
4,676
2,370
3,205
3,180
3,569
12,271
2,057
1,986
1,939
4,260
698
640
582
2,230
11,581
11,780
12,326
8,093
26,722
26,432
26,553
7,143
7,072
7,257
6,059
6,275
4,790
4,316
4,537
4,858
6,920
7,356
7,016
0
6,464
3,135
0
0
003,1356,46407,0167,3566,9204,8584,5374,3164,7906,2756,0597,2577,0727,14326,55326,43226,7228,09312,32611,78011,5812,2305826406984,2601,9391,9862,05712,2713,5693,1803,2052,3704,6764,6654,6344,5965,9592,3253,3444,3183,2913,2693,2731016625230519607385959595959747374744634633,2573,4062,6842,6451511504,1893,6423,4261,3461,2576,2634,9529114,8954,9104,8626426,7436,7637,5691,736000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51,648
0
0
0
70,662
0
0
0
89,244
0
0
0
46,966
0
0
0
34,778
0
0
0
26,265
0
0
0
22,778
0
0
0
13,444
0
0
0
17,679
0
0
0
0
0
0
0
0
0000000017,67900013,44400022,77800026,26500034,77800046,96600089,24400070,66200051,648000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,400
0
0
0
0
0
7,500
0
0
0
10,600
0
0
0
7,100
0
8,800
7,100
14,600
15,600
17,200
18,300
23,000
22,954
43,705
48,829
54,733
56,112
54,733
58,266
56,222
57,826
56,222
60,176
62,598
65,613
62,598
72,989
80,262
80,262
115,139
116,594
116,138
116,138
126,984
131,899
133,618
135,466
158,364
163,074
167,262
167,262
175,825
176,610
136,845
136,845
147,303
147,814
65,905
65,905
72,119
76,178
79,344
79,344
132,689
136,743
141,287
141,287
147,088
148,971
151,332
151,332
159,678
165,057
169,380
169,380
174,817
175,130
183,011
183,011
196,108
194,779
196,975
201,239
205,061
210,997
213,888
213,888
210,663
210,400
108,727
108,727
106,866
106,387
65,196
65,196
66,694
68,083
44,054
44,054
39,072
38,932
4,713
4,713
-712
7,071
-2,219
-2,219
-496
810
-319
-319
15,819
-2,176
-6,618
-2,176
-11,380
-17,487
-23,949
-23,949-17,487-11,380-2,176-6,618-2,17615,819-319-319810-496-2,219-2,2197,071-7124,7134,71338,93239,07244,05444,05468,08366,69465,19665,196106,387106,866108,727108,727210,400210,663213,888213,888210,997205,061201,239196,975194,779196,108183,011183,011175,130174,817169,380169,380165,057159,678151,332151,332148,971147,088141,287141,287136,743132,68979,34479,34476,17872,11965,90565,905147,814147,303136,845136,845176,610175,825167,262167,262163,074158,364135,466133,618131,899126,984116,138116,138116,594115,13980,26280,26272,98962,59865,61362,59860,17656,22257,82656,22258,26654,73356,11254,73348,82943,70522,95423,00018,30017,20015,60014,6007,1008,80007,10000010,6000007,500000002,400000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
400
400
400
500
460
539
559
603
603
603
603
603
603
603
603
610
619
610
643
670
670
774
805
776
776
790
818
830
830
957
967
978
978
989
990
991
991
1,070
1,070
1,070
1,070
1,072
1,079
1,080
1,080
1,083
1,087
1,092
1,092
1,097
1,103
1,106
1,106
1,117
1,125
1,134
1,134
1,158
1,169
1,182
1,182
1,202
1,203
1,204
1,215
1,216
1,216
1,220
1,220
1,221
1,222
1,224
1,224
1,176
1,224
1,224
1,224
1,224
1,224
1,224
1,224
1,213
1,213
1,224
1,224
1,224
1,213
1,213
1,213
1,213
1,213
1,213
1,213
1,963
1,963
1,967
1,963
1,972
1,972
1,972
1,9721,9721,9721,9631,9671,9631,9631,2131,2131,2131,2131,2131,2131,2131,2241,2241,2241,2131,2131,2241,2241,2241,2241,2241,2241,2241,1761,2241,2241,2221,2211,2201,2201,2161,2161,2151,2041,2031,2021,1821,1821,1691,1581,1341,1341,1251,1171,1061,1061,1031,0971,0921,0921,0871,0831,0801,0801,0791,0721,0701,0701,0701,070991991990989978978967957830830818790776776805774670670643610619610603603603603603603603603559539460500400400400400000000000000000000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,400
-4,500
-4,300
-26,100
-9,200
-4,637
-4,685
-6,932
-5,203
0
-5,203
0
-5,054
0
-5,054
0
-4,448
-4,466
-4,448
-8,279
-3,836
-3,836
0
0
-6,079
-6,079
-5,285
0
2,281
2,475
3,343
3,357
3,692
3,692
3,841
0
4,801
4,801
6,223
5,169
0
-2,200
-800
400
400
400
-544
-544
-544
-544
0
0
-1,000
-1,000
0
0
4,135
4,135
4,463
3,916
4,325
4,325
3,672
2,321
-26
-2,463
-2,056
-3,661
-4,809
-4,809
-3,721
-4,002
-1,688
-1,688
-1,409
-792
1,628
1,628
1,853
2,347
2,275
2,275
-28,479
-28,930
-24,212
-24,212
0
-25,994
-5,270
-5,270
-5,067
-5,353
-5,356
-5,356
-5,416
-5,689
-5,764
-5,689
-5,605
-5,730
1,003
1,003-5,730-5,605-5,689-5,764-5,689-5,416-5,356-5,356-5,353-5,067-5,270-5,270-25,9940-24,212-24,212-28,930-28,4792,2752,2752,3471,8531,6281,628-792-1,409-1,688-1,688-4,002-3,721-4,809-4,809-3,661-2,056-2,463-262,3213,6724,3254,3253,9164,4634,1354,13500-1,000-1,00000-544-544-544-544400400400-800-2,20005,1696,2234,8014,80103,8413,6923,6923,3573,3432,4752,2810-5,285-6,079-6,07900-3,836-3,836-8,279-4,448-4,466-4,4480-5,0540-5,0540-5,2030-5,203-6,932-4,685-4,637-9,200-26,100-4,300-4,500-4,400000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,187
16,187
16,187
16,187
16,187
16,187
16,187
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000016,18716,18716,18716,18716,18716,18716,1870000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000-26,074-24,922-28,930-28,479-28,573-28,688000-24,783000-17,327000-7,367000-7,367000-7,367000-7,367000-6,0940000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
6,500
0
0
0
0
0
16,200
0
0
0
19,100
0
0
0
13,000
0
13,700
13,000
44,200
44,400
44,700
44,700
52,400
47,864
65,583
71,198
75,242
75,327
75,242
75,355
75,132
75,175
75,132
75,175
75,886
77,217
75,886
80,625
87,596
87,596
120,495
120,516
120,444
120,444
123,907
127,063
124,227
124,273
148,023
149,804
151,774
151,774
153,877
0
153,961
153,961
159,886
159,876
164,328
164,328
165,545
165,221
164,934
164,934
164,961
161,220
161,599
161,599
2,055
2,683
-2,902
-2,902
7,577
8,830
-2,229
-2,229
5,858
7,006
1,475
1,475
12,097
12,295
5,055
14,393
14,533
14,560
8,159
8,159
15,575
15,801
-1,140
-1,140
16,122
16,077
-8,596
-8,596
16,187
16,187
-8,735
-8,735
16,187
16,187
-8,735
-8,735
-10,130
16,187
-8,735
-8,735
-8,735
-8,735
-8,735
-8,735
28,375
28,245
28,319
28,245
28,406
28,406
21,720
21,72028,40628,40628,24528,31928,24528,375-8,735-8,735-8,735-8,735-8,735-8,73516,187-10,130-8,735-8,73516,18716,187-8,735-8,73516,18716,187-8,596-8,59616,07716,122-1,140-1,14015,80115,5758,1598,15914,56014,53314,3935,05512,29512,0971,4751,4757,0065,858-2,229-2,2298,8307,577-2,902-2,9022,6832,055161,599161,599161,220164,961164,934164,934165,221165,545164,328164,328159,876159,886153,961153,9610153,877151,774151,774149,804148,023124,273124,227127,063123,907120,444120,444120,516120,49587,59687,59680,62575,88677,21775,88675,17575,13275,17575,13275,35575,24275,32775,24271,19865,58347,86452,40044,70044,70044,40044,20013,00013,700013,00000019,10000016,200000006,500000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue56,832
Cost of Revenue-38,328
Gross Profit18,50418,504
 
Operating Income (+$)
Gross Profit18,504
Operating Expense-34,585
Operating Income-16,081-16,081
 
Operating Expense (+$)
Research Development4,379
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense34,5854,379
 
Net Interest Income (+$)
Interest Income0
Interest Expense-11,053
Other Finance Cost-11,053
Net Interest Income0
 
Pretax Income (+$)
Operating Income-16,081
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-36,9274,765
EBIT - interestExpense = -27,134
-24,077
-12,965
Interest Expense11,053
Earnings Before Interest and Taxes (EBIT)-16,081-25,874
Earnings Before Interest and Taxes (EBITDA)-14,304
 
After tax Income (+$)
Income Before Tax-36,927
Tax Provision-0
Net Income From Continuing Ops0-36,927
Net Income-24,018
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses72,913
Total Other Income/Expenses Net-20,8460
 

Technical Analysis of Trinity Biotech plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Trinity Biotech plc. The general trend of Trinity Biotech plc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Trinity Biotech plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Trinity Biotech plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.875 < 1.875 < 2.08.

The bearish price targets are: 1.79.

Tweet this
Trinity Biotech plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Trinity Biotech plc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Trinity Biotech plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Trinity Biotech plc. The current macd is -0.084704.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Trinity Biotech plc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Trinity Biotech plc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Trinity Biotech plc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Trinity Biotech plc Daily Moving Average Convergence/Divergence (MACD) ChartTrinity Biotech plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Trinity Biotech plc. The current adx is 8.60521055.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Trinity Biotech plc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Trinity Biotech plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Trinity Biotech plc. The current sar is 1.79492.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Trinity Biotech plc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Trinity Biotech plc. The current rsi is 37.78. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Trinity Biotech plc Daily Relative Strength Index (RSI) ChartTrinity Biotech plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Trinity Biotech plc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Trinity Biotech plc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Trinity Biotech plc Daily Stochastic Oscillator ChartTrinity Biotech plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Trinity Biotech plc. The current cci is -43.33351209.

Trinity Biotech plc Daily Commodity Channel Index (CCI) ChartTrinity Biotech plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Trinity Biotech plc. The current cmo is -24.09538078.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Trinity Biotech plc Daily Chande Momentum Oscillator (CMO) ChartTrinity Biotech plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Trinity Biotech plc. The current willr is -87.09677419.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Trinity Biotech plc Daily Williams %R ChartTrinity Biotech plc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Trinity Biotech plc.

Trinity Biotech plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Trinity Biotech plc. The current atr is 0.1068154.

Trinity Biotech plc Daily Average True Range (ATR) ChartTrinity Biotech plc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Trinity Biotech plc. The current obv is 4,449,589.

Trinity Biotech plc Daily On-Balance Volume (OBV) ChartTrinity Biotech plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Trinity Biotech plc. The current mfi is 24.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Trinity Biotech plc Daily Money Flow Index (MFI) ChartTrinity Biotech plc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Trinity Biotech plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Trinity Biotech plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Trinity Biotech plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.778
Ma 20Greater thanMa 501.900
Ma 50Greater thanMa 1002.110
Ma 100Greater thanMa 2002.262
OpenGreater thanClose1.880
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Trinity Biotech plc with someone you think should read this too:
  • Are you bullish or bearish on Trinity Biotech plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Trinity Biotech plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Trinity Biotech plc

I send you an email if I find something interesting about Trinity Biotech plc.


Comments

How you think about this?

Leave a comment

Stay informed about Trinity Biotech plc.

Receive notifications about Trinity Biotech plc in your mailbox!